Non invasive evaluation of endothelial function in patients with Anderson-Fabry disease

International Angiology

Volumn 24, Issue 3, 2005, Pages 295-299

  Puccio, D ^a   Coppola, G ^a   Corrado, E ^a   Muratori, I ^a   Pistone, G ^a   Buongiorno, M R ^a   Arico M ^a   Novo, S ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cardiovascular diseases; Endothelial dysfunction; Fabry's disease; Risk factors

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; GLUCOSE; GLYCERYL TRINITRATE; GLYCOSPHINGOLIPID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AMINO ACID BLOOD LEVEL; ANAMNESIS; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY WEIGHT; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ELECTROCARDIOGRAPHY; ENDOTHELIUM LESION; FABRY DISEASE; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPEREMIA; ISCHEMIA; MALE; NON INVASIVE MEASUREMENT; PATHOGENESIS; PHYSICAL EXAMINATION; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; X CHROMOSOME RECESSIVE DISORDER;

ADULT; BRACHIAL ARTERY; C-REACTIVE PROTEIN; ELECTROCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FABRY DISEASE; FEMALE; HUMANS; HYPEREMIA; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; VASODILATION;

EID: 27744479349     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA 1999;281: 249-54.
2. Poorthuis BJ, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, van Weely S et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 1999;105: 151-6.
3. Desnick RJ, Ioannou YA, Eng CM. α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. 7th ed. Vol. II. New York, McGraw-Hill, Inc.; 1995.p.2741-84.
4. Brady RO, Schiffmann R. Clinical features of and recent advances in therapy for Fabry Disease. JAMA 2000;284:2771-5.
5. Bongiorno MR, Pistone G, Aricò M. Fabry disease: enzyme replacement therapy. J Eur Acad Dermatol Venereol 2003;17:676-9.
6. von Scheidt W, Eng CM, Fitzmaurice TF, Erdmann E, Hubner G, Olsen EG et al. An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med 1991;324:395-9.
7. Elleder M, Bradova V, Smid F, Budesinsky M, Harzer K, Kustermann-Kuhn B et al. Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 1990;417:449-55.
8. Kampmann C, Wiethoff CM, Perrot A, Beck M, Dietz R, Osterziel KJ. The heart in Anderson Fabry disease. Z Kardiol 2002;91:786-95.
9. Pochis WT, Litzow JT, King BG, Kenny D. Electrophysiologic findings in Fabry's disease with a short PR interval. Am J Cardiol 1994;74:203-4.
10. Linhart A, Palecek T, Bultas J, Ferguson JJ, Hrudova J, Karetova D et al. New insights in cardiac structural changes in patients with Fabry's disease. Am Heart J 2000;139:1101-8.
11. MacDermot K, Brown A, Jones Y, Zuckerman J. Enzyme replacement therapy reverses the cardiomyopathy of Fabry disease: results of a randomized, double-blind, placebo-controlled trial. Euro J Hum Genet 2001;92:Abstract C074.
12. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
13. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D et al. Close relationship of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995;26:1235-41.
14. Mitsias P, Levine SR. Cerebrovascular complications of Fabry's disease. Ann Neurol 1996;40:8-17.
15. Altarescu G, Moore DF, Pursley R, Campia U, Goldstein S, Bryant M et al. Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke 2001;32:1559-62.